Skip to search formSkip to main contentSkip to account menu

ST 1535

Known as: ST-1535, ST1535 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The Role and Development of the Antagonist of Adenosine A2A in Parkinson’s Disease
Adenosine is a neuromodulator that regulates the body’s response to dopamine and another neurotransmitter in the brain that is… 
2015
2015
Potent, Metabolically Stable 2‐Alkyl‐8‐(2H‐1,2,3‐triazol‐2‐yl)‐9H‐adenines as Adenosine A2A Receptor Ligands
Inhibition of adenosine A2A receptors has been shown to elicit a therapeutic response in preclinical animal models of Parkinson’s… 
2010
2010
Adenosine A2A Receptor Binding Profile of Two Antagonists, ST1535 and KW6002: Consideration on the Presence of Atypical Adenosine A2A Binding Sites
Adenosine A2A receptors seem to exist in typical (more in striatum) and atypical (more in hippocampus and cortex) subtypes. In… 
2008
2008
Behavioural and neurochemical characterization of the adenosine A2A receptor antagonist ST1535.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)